Heterogeneity of epidermal growth factor receptor signalling networks in glioblastoma - Wikidata - awgldk - TriplyDB

Heterogeneity of epidermal growth factor receptor signalling networks in glioblastoma

Heterogeneity of epidermal growth factor receptor signalling networks in glioblastoma

http://www.wikidata.org/entity/Q27013006

about

Soluble Epidermal Growth Factor Receptors (sEGFRs) in Cancer: Biological Aspects and Clinical Relevance Single-cell analysis tools for drug discovery and development Vascular heterogeneity and targeting: the role of YKL-40 in glioblastoma vascularization An LXR-Cholesterol Axis Creates a Metabolic Co-Dependency for Brain Cancers Cooperative tumour cell membrane targeted phototherapy.mTORC2 activity in brain cancer: Extracellular nutrients are required to maintain oncogenic signaling.Anti-Epidermal Growth Factor Receptor Gene Therapy for Glioblastoma EGFR Mutation Promotes Glioblastoma through Epigenome and Transcription Factor Network Remodeling.mTORC2 and Metabolic Reprogramming in GBM: at the Interface of Genetics and Environment.Mir-21-Sox2 Axis Delineates Glioblastoma Subtypes with Prognostic Impact.Dual targeting of glioblastoma with chimeric antigen receptor-engineered natural killer cells overcomes heterogeneity of target antigen expression and enhances antitumor activity and survival.Intratumoral Heterogeneity of the Epigenome.Epidermal growth factor receptor targeting and challenges in glioblastoma.Oncogenic EGFR Represses the TET1 DNA Demethylase to Induce Silencing of Tumor Suppressors in Cancer Cells.Feedback Loop Regulation of SCAP/SREBP-1 by miR-29 Modulates EGFR Signaling-Driven Glioblastoma Growth.Multi-platform molecular profiling of a large cohort of glioblastomas reveals potential therapeutic strategies.An Insight into the Increasing Role of LncRNAs in the Pathogenesis of Gliomas.GBM heterogeneity as a function of variable epidermal growth factor receptor variant III activity.Disabled cell density sensing leads to dysregulated cholesterol synthesis in glioblastoma.Oncogenic role of rab escort protein 1 through EGFR and STAT3 pathway Implications of mitogen-activated protein kinase signaling in glioma.Antiglioma effects of N6-isopentenyladenosine, an endogenous isoprenoid end product, through the downregulation of epidermal growth factor receptor.Diagnostic and Therapeutic Biomarkers in Glioblastoma: Current Status and Future Perspectives.Generation of Microtumors Using 3D Human Biogel Culture System and Patient-derived Glioblastoma Cells for Kinomic Profiling and Drug Response Testing.Nuclear phosphorylated Y142 β-catenin accumulates in astrocytomas and glioblastomas and regulates cell invasion.Nobiletin, a Polymethoxylated Flavone, Inhibits Glioma Cell Growth and Migration via Arresting Cell Cycle and Suppressing MAPK and Akt Pathways.The isoprenoid derivative N6 -benzyladenosine CM223 exerts antitumor effects in glioma patient-derived primary cells through the mevalonate pathway.Investigational new drugs for brain cancer.Concepts in glioma immunotherapy.Signal Peptide Peptidase, Encoded by HM13, Contributes to Tumor Progression by Affecting EGFRvIII Secretion Profiles in Glioblastoma.Single-Cell mRNA Sequencing in Cancer Research: Integrating the Genomic Fingerprint.EGFR and EGFRvIII Promote Angiogenesis and Cell Invasion in Glioblastoma: Combination Therapies for an Effective Treatment.Glioblastoma cellular cross-talk converges on NF-κB to attenuate EGFR inhibitor sensitivity.Multifunctional Transmembrane Protein Ligands for Cell-Specific Targeting of Plasma Membrane-Derived Vesicles Cell adhesion heterogeneity reinforces tumour cell dissemination: novel insights from a mathematical model.Cancer-Associated IDH1 Promotes Growth and Resistance to Targeted Therapies in the Absence of Mutation.Association between ABO blood types and sporadic pancreatic neuroendocrine tumors in the Chinese Han population.Integrating the glioblastoma microenvironment into engineered experimental models.EGF stimulates glioblastoma metastasis by induction of matrix metalloproteinase-9 in an EGFR-dependent mechanism.Old player, new partner: EGFRvIII and cytokine receptor signaling in glioblastoma.

P2860

Q26750970-C736E579-9F1A-457B-88F9-702B93E1A8EA Q26775754-7D9E979E-6951-4427-8F14-E0823F5CBA64 Q26781833-9E8F8354-D4DB-4A8D-B26F-CA8FE902C3A6 Q33822099-B0F04BFC-C295-46C9-9877-938D4C204999 Q33827119-B489699A-1364-4FB0-989E-D5B911B38153 Q33884658-499E7B1B-5CDD-472D-A2AB-5DE3919AD656 Q36155208-90EDD372-3B76-4640-9A9C-A3B9577CAF22 Q36172699-70ADA708-FAD2-48C8-853C-26B8D9220C36 Q36256815-D0F2A4F4-F55C-497F-A0BB-576E501CDCA3 Q36272539-EDB33316-B131-4BC1-8BDF-A6FCA4710951 Q36821054-2D71E6BE-FF5C-46F6-A8AD-F07F3D70BA65 Q36854908-D253B708-6F7D-4248-8D2A-DA464EB3AF4B Q36977684-A9FA1F9C-A82C-4FD2-A7A2-EFF44B061C0F Q37095651-9BFCE935-21DB-4831-A9F3-B4E8359FD20C Q37168356-E8898D7B-AC20-4F3B-9999-489A715A476D Q37225334-BAA32689-A24C-47DA-A463-7BAC73F20AFA Q37670401-DA1B6FBC-D3A8-4DA8-B822-A13639E83488 Q37694758-511C03D4-F0E9-40C6-912C-996A68DDC869 Q37716459-58B01049-F3E4-47AF-BC11-23639E717EF3 Q37745280-ACD74B15-1F08-4E7A-B98F-A6C37457E1CB Q38618205-F078E410-60F6-4F2D-B0A6-1BA334223311 Q38733038-9BA67D85-C401-4D58-BD8D-D577DBBC18AA Q38743138-0BF93583-79F3-4C16-A057-EF80ED1406DB Q38762476-0231EF7A-3F23-495D-AEEC-250A07FAD469 Q38812830-3D0730E2-12EF-49AB-8736-DF466778F070 Q38820034-78247026-DAB6-43CD-A61D-65BEB6D429BF Q38832228-CFB2ADB3-3884-4660-A8EE-6C695C0A92F8 Q38832510-96509E5D-3454-41C4-8BB2-A4EA7BF7BBD5 Q38909071-B4B80DB3-DB18-44AD-9AFB-BAE8C94E1266 Q38960961-BBED9437-F8AE-46BB-B59D-0BCC575ACA73 Q39377159-70EBE4AC-393B-41B2-8B94-D4F2D6E852B6 Q39383476-45797FC6-6DDC-4DFE-BBCE-50105ECCCD92 Q40116157-18AF2EC9-E1DF-4320-A49E-5E83CD67D85A Q41098832-A323F04B-C31C-43D1-B245-641305A46309 Q41361676-C18E17FE-5B38-44AC-8E95-00B9988B9926 Q41468666-290374BD-067C-440E-8B93-A488A1415451 Q41550593-EA2779EA-6929-482D-9045-88958430347D Q41609024-893A6138-2CEF-4505-8C45-0C53A02B7DF2 Q42371599-E33B2904-CB72-407A-B1A4-841ECAF5CC0A Q43441906-A682ADDD-1811-42C6-B660-D7C6CFA6E7A6

P2860

Heterogeneity of epidermal growth factor receptor signalling networks in glioblastoma

http://www.wikidata.org/entity/Q27013006

description

2015 nî lūn-bûn

@nan

2015 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2015 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

name

Heterogeneity of epidermal growth factor receptor signalling networks in glioblastoma

@ast

Heterogeneity of epidermal growth factor receptor signalling networks in glioblastoma

@en

Heterogeneity of epidermal growth factor receptor signalling networks in glioblastoma

@nl

type

label

Heterogeneity of epidermal growth factor receptor signalling networks in glioblastoma

@ast

Heterogeneity of epidermal growth factor receptor signalling networks in glioblastoma

@en

Heterogeneity of epidermal growth factor receptor signalling networks in glioblastoma

@nl

prefLabel

Heterogeneity of epidermal growth factor receptor signalling networks in glioblastoma

@ast

Heterogeneity of epidermal growth factor receptor signalling networks in glioblastoma

@en

Heterogeneity of epidermal growth factor receptor signalling networks in glioblastoma

@nl

P1433

Q27013006-B75FF4BE-D2FD-41D8-B667-49B359B413C4

P1476

Q27013006-38D332A4-648D-45E4-806A-65843D29CCD3

P2093

Q27013006-5735C3B1-26BE-48F5-9B15-F1178C56D3A7

Q27013006-7709C06F-D7BC-4E3E-8C82-C288C11D30D5

Q27013006-D7AF4211-539B-4811-82EB-531A04A64976

P2860

Q27013006-034AC3CA-8BA8-4C28-89DE-B5067B21AE56

Q27013006-08615020-4517-4DD5-B0A0-F3C35D55B018

Q27013006-08842871-7DCF-4726-9F9C-C001B55C8D99

Q27013006-0BF0F02E-D92A-496D-820E-4272FEC9F064

Q27013006-0E835972-4F89-4B70-BF9A-A26496042718

Q27013006-10A86EC3-F574-4AB0-80FA-A58ACD55CDCC

Q27013006-1111FBFF-F90D-4147-B5D5-EF9EFC3E6371

Q27013006-15A6DB48-13E5-4793-8739-4703154E514D

Q27013006-194C285B-3C5C-45C0-A9C6-E9BDBB73947B

Q27013006-1A49666C-2CAE-4C62-A4F3-BEA7F30EEF8B

P2888

Q27013006-35885F79-7EAD-4591-8554-2B4DCBCCAD3C

P304

Q27013006-E7960499-419F-4DDA-AD7D-7D43900B42AB

P31

Q27013006-DEC500EF-B42D-4E7E-BE53-69105A1A2536

P3181

Q27013006-653FCBE9-8CAB-4C65-9951-66D425699CE9

P356

Q27013006-5EE0542A-E718-4231-B6D2-062C39A0EF9E

P407

Q27013006-91BACF12-B66C-436E-A9D7-46361E813C10

P433

Q27013006-7FF45840-3B67-4943-84E9-47C35E8EFD79

P478

Q27013006-1A17A0B4-7F41-4CC2-BA0E-4D773763F14D

P50

Q27013006-D6741BDF-419B-4D2C-8BE8-1735E7A84F90

P577

Q27013006-C68ED380-4B37-42BD-B8A7-7C8C68E9E750

P6179

Q27013006-DE99916D-8511-4639-BB8E-59059AC3E7A1

P698

Q27013006-69AF3152-E5D8-42AB-8E67-FBBAAF440A7C

P932

Q27013006-82967EBE-7F14-49CE-B8BC-4021D18C50D2

P3181

P356

P1433

Nature Reviews Cancer

P1476

Heterogeneity of epidermal growth factor receptor signalling networks in glioblastoma

@en

P2093

Paul S Mischel

http://www.w3.org/2001/XMLSchema#string

Timothy F Cloughesy

http://www.w3.org/2001/XMLSchema#string

Webster K Cavenee

http://www.w3.org/2001/XMLSchema#string

P2860

Evolutionary dynamics of cancer in response to targeted combination therapy

Crystal structure of a truncated epidermal growth factor receptor extracellular domain bound to transforming growth factor alpha

Crystal structure of the complex of human epidermal growth factor and receptor extracellular domains

EGFR phosphorylates tumor-derived EGFRvIII driving STAT3/5 and progression in glioblastoma

Mutational heterogeneity in cancer and the search for new cancer-associated genes

Distant metastasis occurs late during the genetic evolution of pancreatic cancer

Melanomas acquire resistance to B-RAF(V600E) inhibition by RTK or N-RAS upregulation

Comprehensive genomic characterization defines human glioblastoma genes and core pathways

Structural basis for ubiquitin-mediated dimerization and activation of the ubiquitin protein ligase Cbl-b

Molecular determinants of the response of glioblastomas to EGFR kinase inhibitors.

P2888

P304

302-310

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

2221425

http://www.w3.org/2001/XMLSchema#string

P356

10.1038/NRC3918

http://www.w3.org/2001/XMLSchema#string

P407

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

15

http://www.w3.org/2001/XMLSchema#string

P50

Frank B Furnari

P577

2015-04-09T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1023006309

http://www.w3.org/2001/XMLSchema#string

P698

25855404

http://www.w3.org/2001/XMLSchema#string

P932

4875778

http://www.w3.org/2001/XMLSchema#string